OrthoPediatrics (KIDS) Stock Price
OrthoPediatrics Price
Over the last 11 years OrthoPediatrics grew revenue by 23.3% annually, reaching 236.35 M USD. For OrthoPediatrics, the net margin of -16.8% is broadly stable versus -16.6% a few years ago. The consensus 12-month price target for OrthoPediatrics is 25.00 USD, about 14.0% above where the stock trades today. Of 15 analysts, 13 rate the stock a buy — an overall Buy consensus.
OrthoPediatrics stock price
OrthoPediatrics business model & stock analysis
Frequently asked questions about OrthoPediatrics
The business model of OrthoPediatrics Corp revolves around designing, developing, and selling of orthopedic implants and instruments specifically for children. OrthoPediatrics focuses on serving the needs of healthcare professionals who specialize in pediatric orthopedics by offering a comprehensive product portfolio. They aim to improve the quality of life for children with orthopedic conditions, providing innovative solutions tailored to their unique and growing anatomies. OrthoPediatrics' business model is centered on delivering specialized pediatric orthopedic implants, surgical instruments, and related services, thereby catering to the specific requirements of pediatric patients and addressing a niche market in the medical industry.
OrthoPediatrics Corp is primarily active in the medical device industry, specifically focusing on orthopedic products and solutions for children.
Some of the main competitors of OrthoPediatrics Corp in the market include Zimmer Biomet Holdings Inc., Johnson & Johnson, and Stryker Corporation.
OrthoPediatrics Corp is a leading orthopedic company specializing in pediatric orthopedic medical devices and technologies. Founded in 2006, the company has established itself as a prominent player in the market, catering exclusively to the unique needs of children. OrthoPediatrics Corp focuses on developing innovative solutions that address a wide range of orthopedic conditions in pediatric patients. With an extensive product portfolio and a strong commitment to research and development, the company has continuously expanded its presence globally. OrthoPediatrics Corp's dedication to improving the lives of children through orthopedic advancements has earned it a reputable standing in the industry.
OrthoPediatrics Corp has achieved several significant milestones. Since its inception, the company has demonstrated strong growth and innovation. It became the first company to develop a comprehensive pediatric-specific surgical implant offering. OrthoPediatrics Corp has successfully introduced advanced implants and instruments specifically designed for pediatric orthopedic surgery, addressing unmet medical needs. The company has also expanded globally, establishing a presence in over 50 countries, which has further contributed to its success. OrthoPediatrics Corp continues to pioneer in pediatric orthopedics, providing specialized solutions that improve the quality of care for children with musculoskeletal conditions.
OrthoPediatrics Corp is primarily present in the United States.
OrthoPediatrics Corp represents values of innovation, integrity, and commitment to improving pediatric orthopedic care. The company's corporate philosophy revolves around providing advanced solutions to address the unique needs of children, ensuring positive outcomes and improved quality of life. OrthoPediatrics Corp's focus on research and development, collaborative partnerships, and the highest standards of patient care showcases their strong commitment to advancing pediatric orthopedics. By leveraging cutting-edge technology and expertise, OrthoPediatrics Corp strives to enhance surgical procedures, develop innovative implants and instruments, and ultimately make a significant difference in the lives of pediatric patients worldwide.
Analysts currently set an average price target of 24.00 USD for the OrthoPediatrics stock (median: 25.00 USD), implying +9.4 % versus the latest price. The consensus is based on 15 analyst ratings.
15 analysts currently rate the OrthoPediatrics stock: 13 recommend buying, 2 holding and 0 selling. For 2026, analysts expect OrthoPediatrics to generate revenue of 266.99 M USD and earnings per share of -1.30 USD.
Converted at the current exchange rate, the OrthoPediatrics share trades at 19.61 EUR (21.93 USD).
The OrthoPediatrics share (KIDS) is listed on 2 stock exchanges, including: NASDAQ (KIDS), Frankfurt (2X7.F).
OrthoPediatrics Corp is a global provider of orthopedic implants and instruments for the pediatric market. The company was founded in 2006 and is headquartered in the USA. Its goal is to support children and adolescents with orthopedic conditions and enable them to lead active lives. The company has three different business areas: Products, Operative Services, and Education Services. In the Products area, OrthoPediatrics Corp offers a wide range of implants and instruments specifically designed for the treatment of children and adolescents. They offer over 30 surgical systems that can be used for a variety of diagnoses such as scoliosis, hip dysplasia, or fractures. A significant product that OrthoPediatrics Corp offers is the Pediatric Nailing System, a central technology used to manufacture many of their surgical systems. This system is specifically designed for the needs of children and adolescents and facilitates quick and accurate treatment for surgeons. Operative Services is the second business area of OrthoPediatrics Corp. Here, the company offers a variety of service options tailored to the needs of children and adolescents. This includes support for surgery planning, delivery of instruments and implants to the operating site, and providing training for medical personnel. The third business area of OrthoPediatrics Corp is education. The company offers a variety of training programs to educate doctors and medical personnel on the latest technologies and treatment methods for children and adolescents. OrthoPediatrics Corp aims to train doctors and medical personnel on handling children and adolescents through workshops, seminars, and training sessions for doctors, nurses, and other medical staff. OrthoPediatrics Corp's business model is based on the belief that there are no simple operations for children and adolescents. Therefore, the company has developed products and services that consider the specific needs of children and adolescents. The company pursues a strong brand strategy in the pediatric orthopedics market and has established a strong presence in this field. OrthoPediatrics Corp aims to further expand its market position and plans to focus strongly on international markets in the coming years. The company works closely with medical facilities, surgeons, and hospitals to provide advanced technology, excellent service, and training. OrthoPediatrics Corp will continue to be a strong partner for healthcare in the future to ensure that children and adolescents receive the best possible treatment outcomes.
The expected revenue of OrthoPediatrics is 266.99 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of OrthoPediatrics is -30.69 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of OrthoPediatrics is currently -16.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the OrthoPediatrics stock.
The price-to-sales ratio (P/S) of OrthoPediatrics is currently 1.94. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the OrthoPediatrics stock.
The Eulerpool Quality Score for OrthoPediatrics is 4/10.
The ISIN of OrthoPediatrics is US68752L1008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of OrthoPediatrics is A2JAAV. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of OrthoPediatrics is KIDS. The ticker symbol is used to trade OrthoPediatrics shares on the stock exchange.
OrthoPediatrics stock
OrthoPediatrics Peer Group
OrthoPediatrics Ticker
OrthoPediatrics FIGI
All fundamentals and in-depth analysis of OrthoPediatrics
Our stock analysis for OrthoPediatrics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OrthoPediatrics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.